Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 2 CAD -0.5% Market Closed
Market Cap: 129.3m CAD
Have any thoughts about
Arch Biopartners Inc?
Write Note

Arch Biopartners Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arch Biopartners Inc
Total Current Liabilities Peer Comparison

Comparables:
ABCL
RP
IOT

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Arch Biopartners Inc
XTSX:ARCH
Total Current Liabilities
CA$7.6m
CAGR 3-Years
23%
CAGR 5-Years
92%
CAGR 10-Years
32%
Abcellera Biologics Inc
NASDAQ:ABCL
Total Current Liabilities
$119m
CAGR 3-Years
5%
CAGR 5-Years
79%
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Total Current Liabilities
CA$1.5m
CAGR 3-Years
-18%
CAGR 5-Years
-5%
CAGR 10-Years
15%
Innovotech Inc
XTSX:IOT
Total Current Liabilities
CA$171.1k
CAGR 3-Years
21%
CAGR 5-Years
0%
CAGR 10-Years
-13%

See Also

What is Arch Biopartners Inc's Total Current Liabilities?
Total Current Liabilities
7.6m CAD

Based on the financial report for Jun 30, 2024, Arch Biopartners Inc's Total Current Liabilities amounts to 7.6m CAD.

What is Arch Biopartners Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
32%

Over the last year, the Total Current Liabilities growth was 77%. The average annual Total Current Liabilities growth rates for Arch Biopartners Inc have been 23% over the past three years , 92% over the past five years , and 32% over the past ten years .

Back to Top